Navigation Links
China Sky One Medical, Inc. to Acquire Heilongjiang Tianlong Pharmaceutical, Inc.
Date:2/29/2008

HARBIN, China, Feb. 29 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. (''China Sky One Medical'' or ''the Company'') (OTC Bulletin Board: CSKI), a leading manufacturer, marketer, and distributor of over the counter pharmaceuticals for external use in the People's Republic of China (''PRC''), today announced that it has signed an agreement to acquire Heilongjiang Tianlong Pharmaceutical, Inc. (''Tianlong''), an external-use drug manufacturing specialty pharmaceutical company.

Under the terms of the agreement, China Sky One Medical's wholly-owned subsidiary, Harbin Tian Di Ren Medical Science and Technology Company, will acquire 100% of Tianlong's operations for a cash payment $8.0 million and approximately $300,000 of China Sky One Medical's common shares. In exchange, China Sky One Medical will obtain Tianlong's $8.3 million in assets, which include $0.5 million in inventory, land use rights, GMP-certified manufacturing facilities, state-of-the-art production equipment, a research and development center, a portfolio of 69 approved drugs (in 98 forms) and a pipeline of 38 new drugs, all of which have been submitted to the SFDA for approval. The acquisition is expected to close on or before March 31, 2008.

''We expect the synergies of this strategic acquisition to make a significant contribution to our profitability in the coming years. Specifically, Tianlong allows us to broaden our product lines and improve our manufacturing and R&D capabilities. At the same time, we expect to leverage our sales and marketing expertise and the benefits of scale to significantly improve Tianlong's revenues and profitability,'' said Mr. Yan-qing Liu, Chairman, CEO and Director of China Sky One Medical, Inc.

In 2007, Tianlong generated revenue of $5.2 million with a net profit margin of 13%. Following the acquisition, China Sky One Medical expects Tianlong to be accretive to earnings, generating revenues of approximately $7.5 million and net pr
'/>"/>

SOURCE China Sky One Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... (HealthDay News) -- Many viruses and parasites that affect ... -- a bacteria-borne illness than can result in liver ... parks, according to a veterinarian. These germs ... the air, said Dr. Susan Nelson, a clinical associate ... of these serious diseases can be fatal, even with ...
(Date:5/25/2013)... May 25, 2013 Studies from Johns ... are carrying excessive weight and their inability to get ... simply losing weight can naturally relieve many symptoms. ... improvement in sleep quality was significantly associated with overall ... study dated November 6th, 2012, researchers monitored ...
(Date:5/25/2013)... Pradaxa lawsuits filed on ... internal bleeding while using the blood thinner continue to mount ... District of Illinois, Bernstein Liebhard LLP reports. According to ... claims had been filed in the litigation as ... reported by the Court on May 15th. ( In Re: ...
(Date:5/25/2013)... According to a new market report,"Global ... by MarketsandMarkets is expected to reach $544.02 Billion ... analyzes and studies the major market drivers, restraints, ... Rest of the World. , Browse:, ... 87 Figures , 175 Pages ...
(Date:5/25/2013)... 2013 Acuity Games ’ innovative brain ... of Word Hunt is available today, expanding it ... Match, Flash 2, Sudoku and Matchematics will roll out over ... and revolutionary lifetime brain fitness measurement have been re-optimized for ... years of brain fitness measurement in your pocket. What ...
Breaking Medicine News(10 mins):Health News:Hidden Dangers Dog Dog Parks 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 2Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 3Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 4Health News:Acuity Games Apps Come to the iPhone 2
... Get Fit By Finals, , Awards School with a "got ... Bulls legend BJ Armstrong is rallying Chicago teens to ... campaign called Get Fit By Finals . The new ... Body By Milk(R) Campaign and NBA FIT, the NBA,s comprehensive health ...
... potential interaction with cyclosporine could lead to fatal ... -- People taking the immunosuppressant cyclosporine should avoid ... effectiveness and possibly lead to deadly consequences, new ... lab rats taking cyclosporine -- commonly used to ...
... greater fondness for treats, , , WEDNESDAY, March 25 (HealthDay News) ... few bites of dinner but have no problem scarfing down ... their growing bones. , New research suggests that children who ... children growing at a slower rate. , Researchers gave ...
... with Electronic Medical Record Systems enables Medical ... Regulatory RequirementsPROVO, Utah, March 25 eFileCabinet, ... electronic document management (EDM) system with ... (PM) systems which are used by thousands of ...
... Until October 26, 2009 to Regain Compliance with $1.00 Minimum ... Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that it ... an additional three months to regain compliance with ... October 26, 2009 to regain compliance with NASDAQ,s $1.00 minimum ...
... March 25 The 2008 Frost & ... Leadership Award is presented to Ferring Pharmaceuticals. ... initiatives in providing no-needle injection for human ... 2 VISION and ZOMAJET VISION X, innovative ...
Cached Medicine News:Health News:Got Milk?(R) and the NBA Showcase New National Teen Health and Fitness Initiative at Cesar E. Chavez Multicultural Center 2Health News:Got Milk?(R) and the NBA Showcase New National Teen Health and Fitness Initiative at Cesar E. Chavez Multicultural Center 3Health News:Got Milk?(R) and the NBA Showcase New National Teen Health and Fitness Initiative at Cesar E. Chavez Multicultural Center 4Health News:Got Milk?(R) and the NBA Showcase New National Teen Health and Fitness Initiative at Cesar E. Chavez Multicultural Center 5Health News:Licorice May Block Absorption of Organ Transplant Drug 2Health News:A Child's Sweet Tooth May Be All in the Bones 2Health News:A Child's Sweet Tooth May Be All in the Bones 3Health News:eFileCabinet Helps Medical Offices Realize Full Benefits of Electronic Medical Record Systems 2Health News:Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQ's Minimum Bid Price Rule 2Health News:Frost & Sullivan Accolade for Ferring Pharmaceuticals 2Health News:Frost & Sullivan Accolade for Ferring Pharmaceuticals 3
(Date:5/24/2013)... China Biologic Products, Inc. (Nasdaq: CBPO, "China ... biopharmaceutical company in China , today ... public announcement issued by Shanghai RAAS Blood Products Co., ... Stock Exchange, that on May 21, 2013, Ms. ... of the shareholders of the Company, and her spouse, ...
(Date:5/24/2013)... GARDEN CITY, England and ... Heptares Therapeutics, the leading GPCR drug discovery and development company, is ... Usui as a Consultant to augment the Company,s business ... territories. Mr Usui has more than 15 years of ... industry including senior roles at Perlegen Sciences, Inc., Roche Pharma ( ...
(Date:5/23/2013)... May 23, 2013 Amgen (NASDAQ: AMGN ... Annual  Healthcare Conference on Thursday, May 30, 2013, at the ... at 9:20 a.m. Eastern Daylight Time. Arvind Sood ... present at the conference. Live audio of the presentation can ... www.amgen.com , under Investors. A replay of the webcast will ...
Breaking Medicine Technology:China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2
... Published in Journal ,Nutrition, WALTHAM, Mass., Sept. ... today in the journal Nutrition that a botanical,supplement ... that are associated with over-expression of inflammation,and risk ... few studies that recruited,study subjects who have different ...
... Sept. 25 Findings from an international,multicenter, randomized, ... in the treatment of moderate to severe,plaque psoriasis ... the 21st meeting,of the World Congress of Dermatology, ... 2007 in Buenos Aires, Argentina. The presentation, ...
Cached Medicine Technology:Genetic Differences Predict Anti-Inflammatory Benefits From Nutritional Products 2Genetic Differences Predict Anti-Inflammatory Benefits From Nutritional Products 3Genetic Differences Predict Anti-Inflammatory Benefits From Nutritional Products 4Genetic Differences Predict Anti-Inflammatory Benefits From Nutritional Products 5Pivotal Ustekinumab (CNTO 1275) Phase 3 Data to Debut at World Congress of Dermatology Meeting 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: